Hutchison China Meditech Limited Results of Annual General Meeting (5842D)
April 27 2017 - 8:10AM
UK Regulatory
TIDMHCM
RNS Number : 5842D
Hutchison China Meditech Limited
27 April 2017
Results of Annual General Meeting
London: Thursday, April 27, 2017: Hutchison China MediTech
Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces that all
ordinary resolutions and special resolutions put to its Annual
General Meeting ("AGM") held on April 27, 2017 were duly passed.
The poll results of the resolutions were as follows:
Number of Votes (%)*
Resolutions For Against Withheld(#)
To consider and adopt the
audited financial statements
and the reports of the
directors and independent
auditor for the year ended
1 31 December 2016. 50,428,039 80 4
(99.99984%) (0.00016%)
To re-elect Mr Paul Carter
2 as a director. 50,427,873 50 200
(99.99990%) (0.00010%)
To re-elect Mr Johnny Cheng
3 as a director. 50,405,806 22,116 201
(99.95614%) (0.04386%)
To re-elect Dr Dan Eldar
4 as a director. 50,405,776 21,785 562
(99.95680%) (0.04320%)
To re-elect Dr Karen Ferrante
5 as a director. 50,427,873 50 200
(99.99990%) (0.00010%)
To re-elect Mr Graeme Jack
6 as a director. 50,426,736 1,186 201
(99.99765%) (0.00235%)
To re-elect Ms Edith Shih
7 as a director. 50,405,776 21,785 562
(99.95680%) (0.04320%)
To re-elect Dr Weiguo Su
8 as a director. 50,406,168 21,755 200
(99.95686%) (0.04314%)
To re-appoint PricewaterhouseCoopers
as the auditor of the Company
and authorise the board
of directors to fix the
9 auditor's remuneration. 50,424,313 3,380 430
(99.99330%) (0.00670%)
To grant
a general
mandate to
the directors
of the Company
to issue
Ordinary Resolution additional
10 No. 10(A) : shares. 50,423,856 3,913 354
(99.99224%) (0.00776%)
To disapply
pre-emption
Special Resolution rights (Equity
No. 10(B) : Raise). 45,969,701 4,457,156 1,266
(91.16115%) (8.83885%)
To disapply
Special Resolution pre-emption
No. 10(C) : rights (general). 48,240,334 2,186,523 1,266
(95.66397%) (4.33603%)
To grant
a general
mandate to
the directors
of the Company
to repurchase
Ordinary Resolution shares of
No. 10(D) : the Company. 50,427,589 333 201
(99.99934%) (0.00066%)
* Percentages rounded to 5 decimal places
(#) A vote withheld is not a vote in law and is not counted in
the calculation of the proportion of the votes for and againsta
resolution.
As at the date of the AGM, the number of issued shares of
Chi-Med was 60,726,979, which was the total number of shares
entitling the holders to attend and vote on the ordinary
resolutions and special resolutions proposed at the AGM.
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which
researches, develops, manufactures and sells pharmaceuticals and
healthcare products. Its Innovation Platform, Hutchison MediPharma
Limited, focuses on discovering and developing innovative
therapeutics in oncology and autoimmune diseases for the global
market. Its Commercial Platform manufactures, markets, and
distributes prescription drugs and consumer health products in
China.
Chi-Med is majority owned by the multinational conglomerate CK
Hutchison Holdings Limited (SEHK: 0001). For more information,
please visit: www.chi-med.com.
CONTACTS
Investor Enquiries
Christian Hogg, CEO +852 2121 8200
U.K. & International Media Enquiries
Anthony Carlisle, Citigate Dewe Rogerson +44 7973 611 888 (Mobile) anthony.carlisle@cdrconsultancy.co.uk
U.S. Based Media Enquiries
Brad Miles, BMC Communications +1 (917) 570 7340 (Mobile) bmiles@bmccommunications.com
Susan Duffy, BMC Communications +1 (917) 499 8887 (Mobile) sduffy@bmccommunications.com
Investor Relations
Matt Beck, The Trout Group +1 (917) 415 1750 (Mobile) mbeck@troutgroup.com
David Dible, Citigate Dewe Rogerson +44 7967 566 919 (Mobile) david.dible@citigatedr.co.uk
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts +44 (20) 7886 2500
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSEDFDWFWSESL
(END) Dow Jones Newswires
April 27, 2017 09:10 ET (13:10 GMT)
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From May 2024 to Jun 2024
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From Jun 2023 to Jun 2024